Look beyond the walking score
Standing tremor, Parkinson exercise and COPD-related falls—plus swallowing, childhood participation, Duchenne guidance and an allergen recall.
Standing still can be the difficult part. Orthostatic tremor produces shaking and unsteadiness while standing, often easing when a person sits or walks. A new analysis of 244 published cases asks how well the frequency of that shaking captures the person's clinical picture. Most cases fit existing categories; seventeen sat outside them.
A measurement helps describe a problem, but its meaning comes from the task, the person and the question being asked. Today's Parkinson exercise review distinguishes average motor improvement from an individual dose prescription. A COPD review separates associations with falls from proof that a programme prevents them. Two rehabilitation trials show why functional scores and important clinical events deserve separate attention.
All 88 registered sources and 15 study domains were inspected. Discovery retrieved 791 candidate records, including 80 newly retrieved records compared with yesterday's capped searches. Several were published months earlier; retrieval does not make them October news. All 13 unavailable sources were retried without recovery. Two main research texts were read in full; three research summaries and one updated guidance report below use primary abstracts. Actual established guidance, an education resource and a safety announcement were checked separately.
The frequency is a finding to interpret
The review gathered 100 reports containing 244 people with electromyography-confirmed orthostatic tremor. Electromyography, or EMG, records muscle electrical activity. The search extended through February 2026 and included case reports, case series and original studies providing individual data. This was a synthesis of selected published cases, rather than a prospective diagnostic trial.
Mean tremor frequency was 13.32 Hz, with a range of 3–20 Hz; Hz means cycles per second. The authors assigned 127 cases to primary orthostatic tremor, 39 to orthostatic tremor with additional neurological signs, and 61 to the lower-frequency category called pseudo-orthostatic tremor. Twelve cases crossed the 13-Hz boundary over their reported frequency range; five exceeded 18 Hz. Those seventeen cases could not be definitively classified within the existing framework.
In a separate operational grouping, 148 cases were isolated and 96 had associated conditions. Non-isolated presentations had a lower mean frequency: 11.03 versus 14.80 Hz. Yet the frequencies overlapped considerably, including among people with Parkinsonian disorders. A frequency does not identify the associated condition by itself.
For an informed patient, the important conversation concerns when unsteadiness occurs and what the examination and recording show together. A result near a category boundary deserves interpretation in that context. This review does not replace existing diagnostic criteria or establish a new treatment.
Clinical notes: what the ROC analysis actually classified
The receiver operating characteristic analysis distinguished isolated from non-isolated presentations within this published-case sample. It did not distinguish orthostatic tremor from healthy standing or diagnose Parkinson's disease. Area under the curve was 0.72, 95% CI 0.60–0.85. A data-derived 10-Hz threshold had 45% sensitivity and 93% specificity for the study's classification task. It is exploratory, with no independent prospective validation reported.
The multivariable association between frequency and non-isolated phenotype was odds ratio 0.78 per Hz, 95% CI 0.71–0.85, adjusting for age, sex and disease duration. This is an association within selected reports. It does not establish a cause, a population prevalence or a probability of future neurodegeneration.
Case publication may overrepresent unusual presentations. Frequency ranges were averaged for analysis, which can obscure variability within a person. Orthostatic myoclonus was excluded; these findings cannot be used to classify all standing-related involuntary movement. The main text and actual Tables 1–3 were read; the underlying case reports and all supplementary patient rows were not independently audited.
Primary orthostatic-tremor review record · Main full review · DOI: 10.5334/tohm.1278
An exercise ranking leaves room for the person
A review synthesized 173 randomized trials across motor symptoms, balance, walking speed and Timed Up and Go performance. The separate outcome networks contained 110, 106, 89 and 96 trials respectively; they should not be added together as independent trials. The accessible abstract did not provide the overall participant count.
Mind–body exercise had the largest reported posterior median effect versus a non-exercise control for the motor examination, UPDRS part III: g = 0.65, 95% credible interval 0.42–0.87. This is a standardized effect, rather than a 65% improvement or 0.65 points on the motor scale. A credible interval expresses uncertainty under the Bayesian model and its assumptions.
The dose analysis examined planned weekly exercise exposure, using metabolic equivalent task minutes, or MET-minutes. One MET-minute combines one minute with an assigned metabolic intensity; equal totals need not describe equivalent activities or equal effort for different people. At the trial level, each additional 250 planned MET-minutes/week was associated with a motor-outcome difference of +0.121 standardized units, 95% credible interval +0.055 to +0.194, after adjustment for exercise category.
Associations were also reported for balance and Timed Up and Go, but not clearly for walking speed. The Timed Up and Go association weakened when the high-dose tail was truncated. Most importantly, all active-versus-control prediction intervals crossed zero, and confidence in the network evidence was low or very low. The review did not establish a universally best modality, an optimal dose or a causal target for an individual patient.
Patients can use the findings to ask which outcome an exercise programme is intended to improve and how preferences, abilities and sustained participation enter the choice. A trial-level dose association is insufficient to prescribe everyone the same weekly target.
Clinical notes: an average effect and a prediction interval answer different questions
A credible interval around an average effect describes uncertainty about that average. A prediction interval also reflects variation between studies when considering an effect in a comparable setting. A favorable average and a prediction interval crossing zero can therefore coexist. The latter is not proof of no benefit; it limits confidence that the favorable average will transfer consistently.
The dose analysis was secondary and used reconstructed planned exposure across trials. Even after adjustment for exercise category, study-level associations may reflect differences in populations, delivery and other study features. Within-class randomized dose-contrast estimates were imprecise for all four outcomes. They did not confirm an individual dose-response prescription.
The publisher page explicitly displayed a subscription preview. We reviewed that preview and the primary PubMed abstract, not the full methods, harms tables, trial-level data or supplementary models. Network confidence is the authors' CINeMA assessment; no independent regrading was performed.
Primary Parkinson exercise review abstract · Publisher abstract and access boundary · DOI: 10.1007/s00415-026-14189-y
Ask about balance as well as breathlessness
A review of falls and related outcomes in chronic obstructive pulmonary disease (COPD) included 25 studies and 1,295 participants. Eighteen studies were cross-sectional; seven followed participants prospectively or longitudinally for five to forty-eight weeks. Searches covered English-language studies through November 2024, so the newly published paper does not cover nearly two years of the most recent research.
Seventeen studies reported a significant association between at least one examined factor and a fall-related outcome. Among seventeen studies assessing balance, fourteen reported an association. Evidence linking muscle strength directly to falls was less consistent. Gait findings also suggested relevant problems, but actual falls, fall history, estimated risk and laboratory movement measures were mixed across studies.
The authors could not pool a quantitative treatment effect because methods and outcomes varied. Counting studies with statistically significant results does not supply the size of an association or show how many falls a programme will prevent. The review supports considering balance and lower-limb function during assessment; it does not establish that adding a particular exercise component reduces actual falls.
For patients, a useful question is whether the rehabilitation assessment includes unsteadiness, falls and everyday mobility alongside respiratory symptoms. That gives the team a fuller account of the problem, without assuming that one weakness explains every fall.
Clinical notes: a correlate, a surrogate and an event
A poor balance score is a functional finding. A history of falling is an event report. A risk classification is an estimate. They are related but distinct outcomes. Improvement in a surrogate score does not automatically establish a reduction in prospective falls.
Cross-sectional designs cannot establish whether an impairment preceded a fall. Potential confounders included medication exposure, cognition and neuropathy. The review excluded studies focused mainly on visual deficits, assistive devices, severe nutritional depletion or isolated medication effects; its scope is therefore narrower than a comprehensive falls assessment.
The authors used fifteen selected Downs and Black checklist items with binary scoring. We appraised the main methods, narrative results, discussion and limitations; table images, supplements and individual included studies were not independently appraised. No standardized COPD fall-prediction battery or universal threshold was established by this review.
Primary COPD falls review record · Main full review · DOI: 10.2147/COPD.S635248
A swallowing score and pneumonia are different outcomes
A report describes a combined low-frequency repetitive transcranial magnetic stimulation (rTMS) and sensory-arousal nursing protocol for acute ischemic stroke with dysphagia and feeding-related upper-limb dysfunction. Representative results came from a single-centre, assessor-blinded trial of 160 patients, randomized to the combined package or routine swallowing-rehabilitation nursing, eighty per group, for two weeks.
The between-group difference in Standardized Swallowing Assessment change favored the combined package by −3.9 points, 95% CI −5.8 to −2.0. Functional Oral Intake Scale change differed by +0.8 levels, 95% CI +0.4 to +1.2. The Penetration–Aspiration Scale difference was −0.9 points, 95% CI −1.5 to −0.3, but that analysis included only participants with paired instrumental assessments: 48 versus 46, rather than all 160 randomized patients.
Aspiration pneumonia occurred in 5 of 80 versus 11 of 80 participants (P = .118). The study did not establish reduced pneumonia risk or a clinically important swallowing benefit. No serious rTMS-related adverse events were reported, but short follow-up and limited numbers cannot establish comprehensive safety.
For patients and families, the practical distinction is between an improvement on an assessment and evidence that eating becomes safer in daily life. Decisions about oral intake still require the clinical swallowing team's assessment.
Clinical notes: the combined package and the instrumental subset
Randomization compared a combined stimulation-and-nursing package with routine nursing. It did not isolate stimulation from sensory input or task practice. A mean difference on the ordinal oral-intake scale is not a guarantee that each patient advances one level.
The instrumental subset can differ from the full trial population. The abstract does not explain all reasons for missing paired assessments or supply a validated clinical-importance threshold for these changes. A nonsignificant pneumonia result neither proves absence of benefit nor confirms the observed numerical reduction. The full protocol, detailed exclusions, longer follow-up and harms procedures remained unavailable after retries.
Primary dysphagia protocol and trial abstract · DOI: 10.3791/72231
A game can be studied through the task it supports
A trial compared motion-detection video games combined with neurodevelopmental therapy against neurodevelopmental therapy alone in children aged 7–13 with hemiparetic cerebral palsy. Eligible children were in Gross Motor Function Classification System levels I–III and Manual Ability Classification System levels 1–3. Twenty-four children completed the twelve-week study, twelve in each group; the abstract did not report a separate initial randomized denominator.
Between-group changes favored the combined programme for the Assistance to Participation Scale (P = .043, d = 0.87) and Duruöz Hand Index (P = .049, d = 0.84). The Nine-Hole Peg Test did not show a statistically significant between-group difference (P = .096, d = 0.71). Confidence intervals were not supplied in the abstract.
This small study suggests that functional hand use and participation may respond differently from performance on a timed dexterity task. It does not show that any game works for every child, or that a moderately sized estimate on the peg test proves a benefit despite uncertainty.
Clinical notes: completed participants, multiple outcomes and dose
The large reported standardized effects come from only twelve completers per arm. Several outcomes were tested; the accessible abstract did not describe multiplicity adjustment, allocation concealment or detailed missing-data handling. Assessments were performed by a blinded physiotherapist.
The authors describe a matched therapy dosage framework in their conclusion, but the full schedules were unavailable and total exposure was not independently checked. There was no longer-term follow-up in the accessible summary. These findings do not establish durability, broad safety or applicability to children outside the studied functional levels.
Primary cerebral-palsy gaming trial abstract · DOI: 10.1080/17518423.2026.2738676
Growth belongs in the rehabilitation conversation
The OPTIMIZE DMD Consortium's Growth and Puberty Working Group reports updated guidance based on a literature review, clinician survey and expert consensus. Long-term glucocorticoid treatment in Duchenne muscular dystrophy can affect growth and pubertal development; the report also considers hypogonadism beyond puberty, vamorolone and gonadal function in older adolescents and adults.
The abstract emphasizes individualized goals, family involvement and communication between endocrine and neuromuscular teams, while acknowledging limited long-term outcome data. Full recommendations were unavailable after retries. We therefore do not reproduce investigation thresholds, hormone regimens or drug-selection advice. This is updated guidance to review with the team, rather than a comparative trial establishing one management strategy.
Primary updated Duchenne guidance abstract · DOI: 10.1177/22143602261486896
The falls assessment reaches beyond a cutoff
NICE's falls guidance applies to people 65 and over, and those 50–64 with factors increasing fall risk. It advises against using prediction tools to predict an individual's risk of falling. Instead, clinicians ask about falls and assess the relevant circumstances.
A comprehensive assessment includes, where appropriate, lying and standing blood pressure, cognition, medications, vision, hearing, footwear, mobility and muscle strength. Community exercise programmes should be tailored, progressive, delivered by appropriately trained professionals and reviewed regularly.
For the eligible community population, a fall in the last year plus frailty, injury requiring treatment, loss of consciousness, inability to get up independently or at least two falls triggers comprehensive assessment and management. This established guidance provides a broader clinical framework than a single timed score. Recommendations 1.1, 1.2 and 1.3.9–1.3.10 were read directly; underlying evidence reviews were not appraised.
Make a repeated test a comparable test
The Timed Up and Go assessment times rising from a chair, walking three metres at a comfortable safe pace, turning, returning and sitting. RehabMeasures describes a practice trial and using the same walking aid at repeat assessments. Chair and pace conditions matter when comparing scores.
Its cutoff table reports different thresholds across populations. They should not be collapsed into a universal prediction rule. We checked the actual administration description, considerations and cutoff table; the underlying validation papers were not independently reviewed. This is measurement education, not a new October update or accredited CME.
An allergen missing from the label
Oliva LLC recalled Riad's Oliva to Go Baba Ghanouj, Spicy Baba Ghanouj and Hummus for undeclared sesame. The notice identifies baba ghanouj varieties with best-by dates October 10–14, 2026 and hummus with dates October 12–18, 2026, distributed around Litchfield County, Connecticut, and Great Barrington, Massachusetts.
People with sesame allergy or severe sensitivity face a risk of serious reactions. The company instructs consumers to return the affected products to the purchase location for a refund or replacement. No illnesses had been reported at the announcement; that is not an assurance that a product with an undeclared allergen is suitable for someone with the allergy. The actual notice was read; packaging photos were not independently appraised.
What does a prediction interval add?
A synthesis reports a favorable average effect with a credible interval excluding zero, but its prediction interval crosses zero. Which interpretation is best supported?
- Every comparable programme should produce the favorable average.
- The intervention has been proved ineffective.
- The average may favor treatment while effects in comparable study settings remain variable and uncertain.
- The analysis establishes an optimal dose for every patient.
Reveal the answer and reasoning
C. Uncertainty about the average and variation between study settings are different questions. A prediction interval crossing zero limits confidence in consistent transfer of the average effect; it does not prove no benefit. Today's Parkinson review also reports low or very low network confidence and imprecise randomized dose contrasts.
A short glossary for the reading room
- Orthostatic tremor
- A tremor occurring during standing, confirmed through muscle electrical recordings. Clinical interpretation includes symptoms and associated findings.
- Electromyography (EMG) and Hz
- EMG records muscle electrical activity. Hz describes cycles per second, not the severity of disability.
- Credible interval
- A Bayesian interval expressing uncertainty about a parameter under the model, data and prior assumptions.
- Confidence interval (CI)
- A range expressing uncertainty around an estimate under the statistical analysis. It does not guarantee an individual result.
- Prediction interval
- A range reflecting uncertainty and variation when considering an effect in a comparable study setting. It differs from uncertainty about an average.
- Standardized effect, g or d
- A difference expressed in standard-deviation units. It is not a percentage improvement or a raw score change.
- Network meta-analysis
- A synthesis of direct and indirect treatment comparisons. Rankings depend on the evidence network and its assumptions.
- MET-minutes
- Minutes combined with assigned metabolic intensity to describe planned activity exposure. The total is not an individual treatment-response guarantee.
- Surrogate outcome
- A measured finding used to represent a clinical problem. Changes in the surrogate do not automatically establish changes in the event of greatest interest.
- Dysphagia and aspiration
- Dysphagia is difficulty swallowing. Aspiration involves material entering the airway below the vocal folds; pneumonia is a separate clinical outcome.
References & the coverage record
- Clinical and Electrophysiological Heterogeneity of Orthostatic Tremor: An Individual Patient Data Analysis. Tremor and other hyperkinetic movements (New York, N.Y.) · PMID 42857721 · DOI 10.5334/tohm.1278
- Exercise modality and planned weekly exercise exposure for motor outcomes in Parkinson's disease: a systematic review, Bayesian network meta-analysis, and meta-regression. Journal of neurology · PMID 42859236 · DOI 10.1007/s00415-026-14189-y
- Neuromuscular, Balance, and Gait Factors Associated with Falls and Fall-Related Outcomes in Individuals with COPD: A Systematic Review. International journal of chronic obstructive pulmonary disease · PMID 42859794 · DOI 10.2147/COPD.S635248
- Low-Frequency Repetitive Transcranial Magnetic Stimulation with Sensory Arousal Nursing for Post-Stroke Dysphagia. Journal of visualized experiments : JoVE · PMID 42858022 · DOI 10.3791/72231
- The effect of video-based games on upper extremity function and activity participation in children with hemiparetic cerebral palsy. Developmental neurorehabilitation · PMID 42857931 · DOI 10.1080/17518423.2026.2738676
- Managing growth and puberty concerns in individuals with Duchenne muscular dystrophy: Updated guidance and future directions. Journal of neuromuscular diseases · PMID 42857968 · DOI 10.1177/22143602261486896
Five research reports and one updated guidance report were appraised. The orthostatic-tremor review main text and actual Tables 1–3, and the COPD falls review main methods, narrative results, discussion and limitations were read. COPD table images, supplements, underlying studies and the full supplementary case dataset were not independently appraised. Parkinson exercise, dysphagia stimulation/nursing and cerebral-palsy gaming summaries use primary abstracts; the Parkinson publisher page was a subscription preview, not full-text access, and retries did not supply the other full reports. The updated OPTIMIZE DMD growth/puberty report was read through its primary abstract; exact investigation and treatment recommendations remained unavailable. Actual NICE NG249 recommendations 1.1, 1.2 and 1.3.9–1.3.10 were read as established 2025 guidance. Actual RehabMeasures Timed Up and Go descriptions, considerations and cutoff table were read as established education, not the underlying validation papers. The actual FDA-posted Oliva sesame recall announcement dated October 9 was checked; product photos were not independently appraised. A separate device-recall search lead was not corroborated through accessible primary content and was excluded from clinical claims. Other guideline sections, underlying evidence reviews, licensed chapters, paid courses and audio/video transcripts were not appraised. All 13 inaccessible registered sources were retried without recovery. Newly retrieved metadata includes older publication dates; removals from capped searches are not retractions. No physician review has been recorded. This is independent education, not accredited CME or official examination material.
The discovery window was 2026/09/11–2026/10/11. A journal index check can miss work not yet indexed. A retrieved landing page does not verify every linked publication, paid course, podcast or textbook chapter. Candidate counts are discovery records, not validated practice changes.
See every registered source and its status → · Download this edition’s machine-readable coverage record
Educational, not medical advice. Discuss treatment choices with your clinician. Sources and evidence evolve; each dated edition preserves what was checked for that issue.